Fellowship · Portland, OR
Sponsored by Oregon Health & Science University (OHSU Health)
Medical Management and Revascularization for Asymptomatic Carotid Stenosis.
The New England journal of medicine · 2026 · 73 citations · Wayne Clark
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
JAMA · 2024 · 190 citations · Wayne Clark
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection.
The New England journal of medicine · 2024 · 158 citations · Wayne Clark
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Neurology and therapy · 2023 · 115 citations · Jason Aldred
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
The Lancet. Neurology · 2022 · 182 citations · Jason Aldred
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Brain : a journal of neurology · 2024 · 89 citations · Jason Aldred
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
Science translational medicine · 2022 · 199 citations · Jason Aldred
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.
The Lancet. Neurology · 2024 · 86 citations · Helmi Lutsep